Friday, May 30, 2025

Latest

Mind Medicine Sees Final Co-Founder Leave The Company

Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets, the firm indicated that the final co-founder of the company had resigned.

Stephen Hurst is the last of the firms co-founders to leave an executive role at the company, announcing on Friday he would be resigning as a director. Despite his departure after the firm being public for a short time, he referred to the company as, “the culmination of [his] career.”

The announcement follows filings made by Hurst earlier this week in relation to his holdings of the company, indicating that during the final week of 2021 he sold off his entire position held via Savant HWP, Inc. A total of 1.1 million shares were sold for gross proceeds of $1.5 million.

Hurst still holds 1.7 million shares in the firm via Sunray Asset Management, as well as 1.0 million shares via a Hurst Family Charitable Fund, and 39.0 million shares via Savant Addiction Medicine, LLC.

Hurst is the last co-founder of the firm to resign, following JR Rahn’s well-known departure in mid 2021, as well as Scott Freeman’s departure in August 2020. Additionally, the firm in the final week of 2021 saw the departure of its Chief Technology Officer, as well as its Chief Scientific Officer.

Mind Medicine last traded at $1.55 on the Neo.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

First Majestic Makes Second Major Discovery At Santa Elena In Just A Year

Related News

Mind Medicine Begins Phase 2B Study On Treating Generalized Anxiety Disorder With LSD Variant

Mind Medicine (NEO: MMED) has officially seen patient trials under a Phase 2b study get...

Thursday, August 25, 2022, 08:50:31 AM

Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance

Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The...

Monday, August 29, 2022, 08:21:39 AM

MindMed To Begin Trading On The Nasdaq April 27

MindMed (NEO: MMED) is moving up to the big leagues. The psychedelics company this morning...

Friday, April 23, 2021, 09:11:58 AM

Mind Medicine Completes Pre-IND Meeting For LSD Assisted Therapy In Anxiety

Mind Medicine (NEO: MMED) this morning issued a brief update related two products within its...

Monday, December 14, 2020, 07:54:19 AM

Champignon Brands Vs Mind Medicine: A Comparison

Champignon Brands (CSE: SHRM), prior to the public listing of the company, had a primary...

Monday, April 20, 2020, 09:01:13 AM